Roche Pharmaceutical Development and Sales Overview

Core Lab CHFbn 7.0 2022 vs. 2021 CER growth +5% 6.0 5.0 4.0 3.0 2.0 1.0 0.0 YTD Sep 2020 YTD Sep 2021 YTD Sep 2022 Immunodiagnostics Clinical Chemistry Other CER=Constant Exchange Rates; underlying growth of Core Lab excluding Roche Information Solutions: +5% -4% +8% +6% Roche 171

View entire presentation